Pericytes and endothelial precursor cells: Cellular interactions and contributions to malignancy

Cancer Research

Volumn 65, Issue 21, 2005, Pages 9741-9750

  Bagley, Rebecca G ^a   Weber, William ^a   Rouleau, Cecile ^a   Teicher, Beverly A ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL ANTIGEN; CELL SURFACE MARKER; CELL SURFACE PROTEIN; DESMIN; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NEURAL GROWTH PROTEOGLYCAN 2; PHOSPHOTRANSFERASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEOGLYCAN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ASSAY; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CELL TYPE; COCULTURE; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MICROVASCULATURE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TUMOR GROWTH; TUMOR MODEL; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; GROWTH SUBSTANCES; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 27544475061     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4337     Document Type: Article

References (51)

1. Folkman MJ, Merler E, Abernathy C, et al. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-88.
2. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-8.
3. Diaz-Flores L, Gutierrez R, Varela H, et al. Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopath 1999;6:269-86.
4. Tilton RG, Kilo C, Williamson JR. Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc Res 1979;18:325-35.
5. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996;32:687-98.
6. Gehling U, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106-12.
7. + cells. Br J Haematol 2001;115:186-94.
8. Bagley R, Walter-Yohrling J, Cao X, et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res 2003;63:5866-73.
9. Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002;109:337-46.
10. + hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res 2001;61:7654-9.
11. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2002;7:1194-201.
12. Shirakawa K, Shibuya M, Heike Y, et al. Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. Int J Cancer 2002;99:344-51.
13. Vacca A, Ribatti D, Roccaro AM, et al. Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma. Acta Haematol 2001;106:162-9.
14. Rouget C. Memoire sur le development, la structure et les proprietes physiologiques des capillaires sanguins et lymphatiques. Arch Physiol Norm Pathol 1873;5:603-63.
15. Zimmermann KW. Der feinere Bau der Blutcapillares. Z Anat Entwicklungsgesch 1923;68:3-109.
16. Majno G, Palade GE. Studies on inflammation. I. Effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 1961;11:571-605.
17. De Oliveira F. Pericytes in diabetic retinopathy. Br J Ophthalmol 1966;50:134-43.
18. Morikawa S, Baluk P, Kaidoh T, et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
19. Bergers G, Song S, Meyer-Morse N, et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. Cancer Res 2003;111:1287-95.
20. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-β regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003;112:1142-51.
21. Guo P, Hu B, Wisong G, et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003;162:1083-93.
22. Laird A, Vajkoczy P, Shawver L, et al. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res 2000;60:4152-69.
23. Walter-Yohrling J, Pratt B, Ledbetter S, et al. Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model. Cancer Chemother Pharmacol 2003;52:263-9.
24. Helmbold P, Nayak R, Marsch W, et al. Isolation and in vitro characterization of human dermal microvascular pericytes. Microvasc Res 2001;61:160-5.
25. Ozerdem U, Grako K, Dahlin-Huppe K, et al. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001;222:218-27.
26. Verbeek MM, Westphal JR, Ruiter DJ, et al. T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J Immunol 1995;154:5876-84.
27. Schlingemann RO, Rietveld FJR, Kwaspen F, et al. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 1991;138:1335-47.
28. Nehls V, Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type α-actin. J Cell Biol 1991;113:147-54.
29. Asashima T, Iizasa H, Tersaki T, et al. Rat brain pericyte cell lines expressing β2-adrenergic receptor type 1A, Klotho, and CXCR4 mRNAs despite having endothelial cell markers. J Cell Physiol 2003;197:69-76.
30. Orimo A, Tomioka Y, Shimizu Y, et al. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 2001;7:3097-105.
31. Fong T, Shawver L, Sun L, et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vacularization, and growth of multiple tumor types. Cancer Res 1999;59:99-106.
32. Corbett TH, Polin L, Roberts BJ, et al. Tumor models in cancer research. In: Teicher BA, editor. Totowa (NJ): Humana Press. 2001. p. 50-5.
33. Bono P, Wasenuis V, Heikkila P, et al. High LYVE-1 positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 2004;10:7144-9.
34. Nehls V, Drenckhahn D. The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochem J 1993;99:1-12.
35. + cells infused best predict late haematopoietic constitution following autologous peripheral blood stem cell transplantation. Br J Haematol 2002;117:238-44.
36. Bompais H, Chagraoui J, Canron X, et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004;103:2577-84.
37. Rehman J, Li J, Orschell C, et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9.
38. Tontsch U, Bauer HC. Isolation, characterization, and long-term cultivation of porcine and murine cerebral capillary endothelial cells. Microvasc Res 1989;37:148-61.
39. Capillo M, Mancuso P, Gobbi A, et al. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin Cancer Res 2003;9:377-82.
40. Schuch G, Heymach J, Nomi M, et al. Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res 2003;63:8345-50.
41. Monestiroli S, Mancuso P, Burlini A, et al. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res 2001;61:4341-4.
42. Mancuso P, Calleri A, Cassi C, et al. Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 2003;522:83-97.
43. Sussman L, Upalakalin J, Roberts M, et al. Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther 2003;2:255-6.
44. Rabascio C, Muratori E, Mancuso P, et al. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res 2004;64:4373-7.
45. Machein M, Renninger S, Lima-Hahn E, et al. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 2003;13:582-7.
46. Gothert J, Gustin S, van Eekelen A, et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004;104:1769-77.
47. Tie K, Kawakami-Kimura N, Taguchi O, et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res 2002;62:6289-96.
48. Eberhard A, Kahlert S, Goede V, et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388-93.
49. Hellstrom M, Kalen M, Lindahl P, et al. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999;126:3047-55.
50. Bjarnegard M, Enge M, Norlin J, et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2003;131:1847-57.
51. Erber R, Thurnher A, Katsen A, et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 2004;18:338-40.